465
Participants
Start Date
May 11, 2020
Primary Completion Date
May 10, 2021
Study Completion Date
October 14, 2021
Therapeutic Anticoagulation
The choice of low molecular weight heparin (LMWH) versus unfractionated heparin (UFH) will be at the clinician's discretion. LMWH options include: Tinzaparin, Enoxaparin or Dalteparin. UFH will be administered using a weight-based nomogram with titration according to center-specific institutional protocol.
St. Michael's Hospital, Toronto
Collaborators (1)
University of Vermont Medical Center
OTHER
University of Sao Paulo
OTHER
Hopital Charles Lemoyne
OTHER
William Osler Health System
OTHER
MOUNT SINAI HOSPITAL
OTHER
Trillium Health Partners
OTHER
St. Joseph's Health Centre Toronto
OTHER
The Ottawa Hospital
OTHER
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
OTHER
Michael Garron Hospital
OTHER
University of Alberta
OTHER
Southlake Regional Health Centre
OTHER
Maisonneuve-Rosemont Hospital
OTHER
Queen Elizabeth II Health Sciences Centre
OTHER
Foothills Medical Centre
OTHER
Alberta Health services
OTHER
Peter Lougheed Centre
OTHER
Mater Misericordiae University Hospital
OTHER
King Saud Medical City
OTHER_GOV
King Fahad Medical City
OTHER_GOV
King Faisal Specialist Hospital & Research Center
OTHER
Versiti
OTHER
Barnes-Jewish Hospital
OTHER
Al Ain Hospital
OTHER
Unity Health Toronto
OTHER